Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma - Authors' reply.

Authors:

Chiappella A, Martelli M, Evangelista A, Vitolo U.

Source:

Lancet Oncol 2017; 18: e558. (IF 33.9)

This website only uses technical cookies and does not collect personal data or use profiling cookies. By continuing to browse, you accept the use of cookies.